---
title: "CICC Keeps Their Buy Rating on Hansoh Pharmaceutical Group Company Limited (3692)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281675989.md"
description: "CICC analyst maintained a Buy rating on Hansoh Pharmaceutical Group Company Limited yesterday and set a price target of HK$52.00.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In a report released on April 2, CMB International Securities also maintained a Buy rating on the stock with a HK$46.41 price target."
datetime: "2026-04-04T05:56:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281675989.md)
  - [en](https://longbridge.com/en/news/281675989.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281675989.md)
---

# CICC Keeps Their Buy Rating on Hansoh Pharmaceutical Group Company Limited (3692)

CICC analyst maintained a Buy rating on Hansoh Pharmaceutical Group Company Limited yesterday and set a price target of HK$52.00.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In a report released on April 2, CMB International Securities also maintained a Buy rating on the stock with a HK$46.41 price target.

### Related Stocks

- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [03692.HK](https://longbridge.com/en/quote/03692.HK.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)

## Related News & Research

- [Sunshine Lake Pharma Wins NMPA Acceptance for Innovative Vonoprazan Injection for Peptic Ulcer Bleeding](https://longbridge.com/en/news/282019095.md)
- [Hansoh Pharmaceutical Group (SEHK:3692) Net Margin Strength Backs Bullish Narratives](https://longbridge.com/en/news/281032561.md)
- [Ascletis Pharma Selects Oral Obesity Drug Combination for Clinical Development](https://longbridge.com/en/news/281968452.md)
- [Sino Biopharm Wins FDA IND Nod for Pan-KRAS Cancer Drug TQB3205](https://longbridge.com/en/news/282119054.md)
- [Seres Group Refines AGM Agenda With Detailed Share Buyback Resolutions](https://longbridge.com/en/news/281431575.md)